CURRENT VIEWS ON THE ORAL BIOAVAILABILITY OF INORGANIC MERCURY IN SOIL - IMPLICATIONS FOR HEALTH RISK ASSESSMENTS

Citation
Dj. Paustenbach et al., CURRENT VIEWS ON THE ORAL BIOAVAILABILITY OF INORGANIC MERCURY IN SOIL - IMPLICATIONS FOR HEALTH RISK ASSESSMENTS, Risk analysis, 17(5), 1997, pp. 533-544
Citations number
52
Categorie Soggetti
Social Sciences, Mathematical Methods
Journal title
ISSN journal
02724332
Volume
17
Issue
5
Year of publication
1997
Pages
533 - 544
Database
ISI
SICI code
0272-4332(1997)17:5<533:CVOTOB>2.0.ZU;2-R
Abstract
Due to the presence of mercury at a number of major contaminated sites in the United States, the bioavailability of inorganic mercury in soi l following ingestion has emerged as an important public health issue. Studies of the leachability/solubility of inorganic mercury in soil h ave shown that it is largely immobile, thereby suggesting that it will not be readily available for absorption in the gastrointestinal tract . Ignoring the effect of the soil matrix on decreasing bioavailability may result in a substantial overprediction of risks due to ingestion of contaminated soil. This paper discusses current knowledge about the oral bioavailability of inorganic mercury in soil and offers suggesti ons about how these data may be applied in human health risk assessmen t. Though precise estimates are not available, in vivo and in vitro es timates of the bioavailability of different inorganic mercury species in different matrices suggest that the bioavailability of mercury in s oil is likely to be significantly less, on the order of at least three -to tenfold, than the bioavailability of mercuric chloride, the specie s used to derive the toxicity criteria for inorganic mercury. Because bioavailability can vary significantly with soil type, soil aging, the presence of co-contaminants and other factors, it is suggested that w henever the fiscal aspects justify a more precise estimate of bioavail ability, site-specific estimates be developed. To develop a database f or identifying a less expensive and more efficient method for estimati ng bioavailability, it is suggested that in vivo studies be conducted concurrently with in vitro studies. However, due to the lack of precis ion associated with the derivation of the most widely-used health guid ance value for inorganic mercury (the USEPA RfD), additional work to a ddress the uncertainties in the RfD is recommended.